MUC1 and neoplasm: In line with the previous report, 4T1-MUC1 tumors also showed a resistance to PD-1 antibody or MUC1 vaccine alone treatment both in the tumor volumes (Figure S9D) and the overall survival of the treated mice (Figure S9E).